← Back
$AKRO All transactions

Akero Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$334K

Shares

6,210

Price

$54

Filed

Jun 20

Insider

Name

Yale Catriona

Title

Chief Development Officer

CIK

0001779308

Roles

Officer

Transaction Details

Transaction Date

2025-06-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

96,021

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated May 24, 2024, previously adopted by the Reporting Person. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $53.40 to $54.37, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.40 to $55.38, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $55.43 to $55.68, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | The options are vested and currently exercisable.

Filing Info

Accession No.

0000950170-25-088207

Form Type

4

Issuer CIK

0001744659

Yale Catriona's History

Date Ticker Type Value
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D

Other Insiders at AKRO (90d)

No other insider activity at this issuer in the last 90 days.